BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wajsbrot NB, Leite NC, Salles GF, Villela-Nogueira CA. Non-alcoholic fatty liver disease and the impact of genetic, epigenetic and environmental factors in the offspring. World J Gastroenterol 2022; 28(25): 2890-2899 [PMID: 35978876 DOI: 10.3748/wjg.v28.i25.2890]
URL: https://www.wjgnet.com/1007-9327/full/v28/i25/2890.htm
Number Citing Articles
1
Siti Aishah Sulaiman, Vicneswarry Dorairaj, Muhammad Nafiz Haidi Adrus. Genetic Polymorphisms and Diversity in Nonalcoholic Fatty Liver Disease (NAFLD): A Mini ReviewBiomedicines 2022; 11(1): 106 doi: 10.3390/biomedicines11010106
2
Liyun Wang, Kahua Liu, Liang Deng, Guanyu Zhou, Wei Qian, Keshu Xu. Exploration of Perturbed Liver Fibrosis-Related Factors and Collagen Type I in Animal Model of Non-Alcoholic Fatty Liver DiseaseApplied Biochemistry and Biotechnology 2024; 196(6): 3260 doi: 10.1007/s12010-023-04694-5
3
O.E. Abaturov, A.O. Nikulina. Genetic predisposition to metabolic dysfunction-associated fatty liver diseaseCHILD`S HEALTH 2024; 19(3): 162 doi: 10.22141/2224-0551.19.3.2024.1696
4
Gautam Maddineni, Sri J. Obulareddy, Ruchir D. Paladiya, Rohan R. Korsapati, Shika Jain, Herby Jeanty, Fnu Vikash, Nayanika C. Tummala, Samatha Shetty, Arezoo Ghazalgoo, Abinash Mahapatro, Viswanadh Polana, Dhruvan Patel. The role of gut microbiota augmentation in managing non-alcoholic fatty liver disease: an in-depth umbrella review of meta-analyses with grade assessmentAnnals of Medicine & Surgery 2024; 86(8): 4714 doi: 10.1097/MS9.0000000000002276
5
Hui‐Chin Chang, Shuo‐Yan Gau. Letter: hereditary role in non‐alcoholic fatty liver diseaseAlimentary Pharmacology & Therapeutics 2023; 57(2): 274 doi: 10.1111/apt.17317
6
Yu Sun, Yongming Shen, Xiurui Liang, Huilin Zheng, Yitong Zhang. MicroRNAs as Biomarkers and Therapeutic Targets for Nonalcoholic Fatty Liver Disease: A Narrative ReviewClinical Therapeutics 2023; 45(3): 234 doi: 10.1016/j.clinthera.2023.02.001
7
Natalia Balassiano Wajsbrot, Nathalie Carvalho Leite, Paulo Henrique Condeixa Franca, Claudia Regina Lopes Cardoso, Gil Fernando Salles, Cristiane A. Villela-Nogueira. Parental History of Type 2 Diabetes Mellitus and PNPLA3 Polymorphism Increase the Risk of Severe Stages of Nonalcoholic Fatty Liver DiseaseDigestive Diseases and Sciences 2024; 69(2): 634 doi: 10.1007/s10620-023-08214-7
8
Ruowen Li, Mingjian Zhao, Chengxu Miao, Xiaojia Shi, Jinghui Lu. Identification and validation of key biomarkers associated with macrophages in nonalcoholic fatty liver disease based on hdWGCNA and machine learningAging 2023; 15(24): 15451 doi: 10.18632/aging.205374
9
Ziwei Guo, Qinjuan Wu, Pengfei Xie, Jiuchong Wang, Wenliang Lv. Immunomodulation in non-alcoholic fatty liver disease: exploring mechanisms and applicationsFrontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1336493